Ignite Creation Date:
2025-12-24 @ 5:54 PM
Ignite Modification Date:
2026-01-25 @ 3:29 PM
Study NCT ID:
NCT01018368
Status:
COMPLETED
Last Update Posted:
2010-05-10
First Post:
2009-11-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of VX-770 and Rifampin in Healthy Male Subjects
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
VX09-770-009
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Medical Monitor
Old Organization:
Vertex Pharmaceutical Incorporated